Live price temporarily unavailable.
Zura Bio (ZURA) is a Health Care company in the Russell 2000. Latest news and coverage below.
| FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|
| Income statement | ||||
| Operating income | −$2.68M | −$62.6M | −$55.2M | −$75.2M |
| Net income | −$25.7M | −$60.4M | −$52.4M | −$68.7M |
| EPS (diluted) | — | −$2.09 | −$0.60 | −$1.06 |
| Balance sheet | ||||
| Cash and equivalents | $13.8K | $99.8M | $176.5M | $109.4M |
| Total assets | $5.26M | $100.8M | $179.5M | $113.9M |
| Total liabilities | $14.8M | $21.3M | $19.5M | $12.4M |
| Shareholders' equity | −$32.1M | $59.3M | $146.8M | $101.5M |
| Cash flow | ||||
| Operating cash flow | −$1.07M | −$15.1M | −$28.1M | −$64.8M |
| Capital expenditure | — | — | $75.0K | $113.0K |
| Free cash flow | — | — | −$28.2M | −$64.9M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$19.3M | −$15.7M | −$19.3M | −$18.1M | −$19.5M | −$18.4M | −$25.5M | −$29.3M |
| Net income | −$20.7M | −$13.6M | −$17.4M | −$16.0M | −$18.0M | −$17.2M | −$24.2M | −$26.3M |
| EPS (diluted) | −$0.26 | −$0.15 | −$0.19 | −$0.17 | −$0.21 | −$0.49 | −$0.22 | −$0.21 |
| Balance sheet | ||||||||
| Cash and equivalents | $188.2M | $176.5M | $170.6M | $154.5M | $139.0M | $109.4M | $225.6M | $205.1M |
| Total assets | $189.1M | $179.5M | $172.5M | $157.8M | $143.9M | $113.9M | $228.6M | $213.4M |
| Total liabilities | $18.2M | $19.5M | $21.1M | $18.7M | $25.5M | $12.4M | $11.7M | $16.3M |
| Shareholders' equity | $153.0M | $146.8M | $138.2M | $125.9M | $108.2M | $101.5M | $216.9M | $197.1M |
| Cash flow | ||||||||
| Operating cash flow | −$5.65M | −$10.8M | −$11.1M | $11.0M | −$42.5M | −$22.3M | −$18.9M | $18.9M |
| Capital expenditure | $13.0K | $45.0K | $49.0K | −$48.9K | $95.9K | $17.0K | $13.0K | −$13.0K |
| Free cash flow | −$5.67M | −$10.9M | −$11.1M | $11.1M | −$42.6M | −$22.3M | −$18.9M | $18.9M |
From Zura Bio's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Zura Bio in our feed yet.